Lactylation of HDAC1 Confers Resistance to Ferroptosis in Colorectal Cancer
Shanghai Medical College of Fudan University · Fudan University Shanghai Cancer Center · +8 more institutions
Abstract
Abstract Colorectal cancer (CRC) is highly resistant to ferroptosis, which hinders the application of anti‐ferroptosis therapy. Through drug screening, it is found that histone deacetylase inhibitor (HDACi) significantly sensitized CRC to ferroptosis. The combination of HDACi and ferroptosis inducers synergically suppresses CRC growth both in vivo and in vitro. Mechanically, HDACi reduces ferroptosis suppressor protein (FSP1) by promoting its mRNA degradation. Specifically, it is confirmed that HDACi specifically targets HDAC1 and promotes the H3K27ac modification of fat mass‐ and obesity‐associated gene (FTO) and AlkB Homolog 5, RNA Demethylase (ALKBH5), which results in significant activation of FTO and…
Citation impact
- FWCI
- 41.28
- Percentile
- 100%
- References
- 46
Authors
18- ZYZhou Yang
Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center
- WSWei Su
Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center
- QZQinglin Zhang
Wuxi People's Hospital, Nanjing Medical University
- LNLili Niu
Tongji University, Shanghai Pulmonary Hospital
- BFBaijie Feng
Fudan University, Pudong Medical Center
Topics & keywords
- Demethylase
- Trichostatin A
- Cancer research
- HDAC1
- Gene silencing
- Histone deacetylase
- Vorinostat
- Chemistry
- Good health and well-being
Funding
- SAShanghai Anti-Cancer AssociationAward: SACA-AX202213
- NNNational Natural Science Foundation of ChinaAwards: 82303206, 82072951, 82372749
- GOGovernment of Jiangsu Province
- SAScience and Technology Commission of Shanghai MunicipalityAwards: 20Y11914300, 22Y21900100
- NSNatural Science Foundation of Jiangsu ProvinceAwards: BK20231146, BK20231261